Login / Signup

Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics.

Jean-Baptiste GarsiBalázs KomjátiGregorio CulliaImre FejesMelinda SiposZoltán SiposEszter FördősPiroska MarkaczBarbara BalázsNathalie LancelotSylvie BergerEric RaimbaudDavid BrownLaurent-Michel VuillardLaure HaberkornCyprian CukierZoltán SzlávikStephen Hanessian
Published in: ACS medicinal chemistry letters (2022)
On the basis of the knowledge that the proline-rich hot spot PPP RPP region of P(151)PSNPPPRPP(160), an oligopeptide derived from the cytosolic portion of p22 phox (p22), binds to the single functional bis-SH3 domain of the regulatory protein p47 phox (p47), we designed a mimetic of the tripeptide PPP based on NMR and X-ray crystallographic data for the p22(151-161) peptide PPSN PPP RPPA with a peptide construct. Incorporation of the synthetic pseudo-triproline mimetic Pro-Pro-Cyp in a molecule derived from molecular modeling studies led to only a 7-fold diminution in activity in a surface plasmon resonance assay relative to the same molecule containing the natural Pro-Pro-Pro tripeptide. The alternative sequence corresponding to a Pro-Cyp-Pro insertion was inactive. This is a first example of the use of a triproline mimetic to interfere with the formation of the p47-p22 complex, which is critical for the activation of NOX, leading to the production of reactive oxygen species as superoxide anions.
Keyphrases
  • anti inflammatory
  • reactive oxygen species
  • ionic liquid
  • machine learning
  • big data
  • small molecule
  • nitric oxide
  • mass spectrometry
  • artificial intelligence
  • protein protein